Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption. As such, efficient handling and processing of particulates is critical to meeting the stringent guidelines set by the FDA and profitable manufacture of pharmaceutical products. Failed batches can mean the loss of hundreds of thousands of dollars in revenue needed to payback the tremendous up-front investment that is inherent in drug development. A recent US-FDA report on the pharmaceutical industry estimated that worldwide cost savings from manufacturing improvements could be as high as US$ 90 billion per year.
The particulate-based manufacturing processes need to be better understood so that they can be properly designed and controlled. The last decade has seen a shift from empirical formulation efforts to an engineering approach based on a better understanding of particulate behaviours in various processes, facilitated by technological advances in computer modelling, manufacture and measurement techniques.
This conference, by bringing together researchers from industry and academia, will be showcasing and demonstrating how the latest R&D in particulate processing can be applied to pharmaceutical industrial design and optimisation as well as how they can cater to emerging regulatory needs. A combination of oral presentations, poster sessions, and workshops will demonstrate the existing expertise and establish future research needs. This will be a perfect opportunity for participants to learn more about the latest trends in particulate process in pharmaceutical unit operations as well as a chance to interact and share th
|Contact: Kevin Korpics|
Engineering Conferences International